Abiopharma

News list

Baumal Caroline 🔴 sold 3.0K shares of Apellis Pharmaceuticals, Inc. (APLS) at $25.53 Transaction Date: Jan 05, 2026 | Filing ID: 000016

Full text

News bot Jan. 6, 2026, 9:28 p.m.
🔍 Baumal Caroline (Executive)

Company: Apellis Pharmaceuticals, Inc. (APLS)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 3,020
Detailed Transactions and Holdings:
- Sold 3,020 shares of Common Stock at $25.5287 per share (Direct)
  Date: 2026-01-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 91,206.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 3, 2026.
- F2: This includes 925 shares from October 31, 2025 ESPP purchase.